Amantadine treats/prevents influenza A; also Parkinson's, drug-induced movement disorders. Inhibits virus replication, boosts dopamine for movement/symptom reduce. Forms: tablet, capsule, solution for needs.
Development/Approval History
1960s antiviral for influenza A; later Parkinson's/movement. FDA approved 1970s.
Main Benefits
- Antiviral: Prevents/treats influenza A.
- Symptom ease: Improves motor, cuts Parkinson's symptoms.
- Versatile: For drug movement disorders.
- Flexible forms: Various for preferences.
Distinct Features
Dual: Antiviral/dopaminergic; versatile for viruses/neurology.
Vs. Similar
- Dual: Antiviral/dopaminergic.
- Flexible forms: Tablet/capsule/solution.
- Affordable: Vs newer.
Safety/Acceptance
Well-tolerated; common dizziness, lightheaded, nausea. Serious: Heart, allergies, mood changes. Monitor for safety.
Uses
Treated Conditions
- Influenza A: Prevent/treat virus.
- Parkinson's: Improve motor, cut tremors/stiff/slow.
- Drug extrapyramidal: Treat antipsychotic movement.
Usage Signs
Influenza: Fever/chills/aches. Parkinson's: Tremors/stiff/move difficulty.
Dosing/Usage
Adult
Influenza: 200 mg/day single/divided.
Parkinson's: Start 100 mg twice, adjust.
Reactions: 100 mg twice.
Child
Influenza weight-based, provider-guided; not typical Parkinson's/reactions kids.
Elderly
Lower doses sensitivity/effects; start low, adjust response/tolerance.
Timing
Same times daily; with/without food influenza, food Parkinson's GI reduce.
Frequency
Once/twice daily per regimen; consistent for levels/outcomes.
Food Impact
No major, food reduces GI effects.
How It Works
Mechanism
Antiviral: Inhibits influenza replication. Dopaminergic: Boosts dopamine, blocks NMDA for motor/symptoms.
Targets
M2 protein virus prevent replicate. Brain: Dopamine up, NMDA block for control/symptoms.
Metabolism
Minimal liver, unchanged urine; adjust impaired kidney.
Biochem
Inhibits replicate, dopamine up; NMDA block for effects.
Physio
Reduce influenza symptoms fever/aches. Parkinson's: Better motor, less tremors/stiff/slow, quality up.
Ingredients
Active
Amantadine hydrochloride; 100-150 mg strengths.
Inactive
Lactose, magnesium stearate, starch for formulation/stability.
Roles
Amantadine: Main antiviral/dopaminergic; inactive: Stability/absorption.
Effects
Common
Dizziness, lightheaded, dry mouth, constipation, GI discomfort; mild, decrease use.
Rare
Severe allergies, heart (arrhythmias), neuroleptic syndrome.
Serious
Heart signs (irregular beat, faint), allergies (rash/itch/swell/dizzy/breathe), mood (depress/suicidal).
Frequency/Severity
Mild early; serious rare, monitor/follow-ups.
Avoiding
Precautions
Follow dose, no longer than recommended; monitor heart/mental, elderly/pre-existing.
Tolerance
Directed use, follow-ups; educate adherence/response. Food for GI.
Restrictions
Conditions
Hypersensitivity amantadine/components; severe kidney, seizure/psychiatric history.
Reasons
Worsen kidney/psychiatric via CNS/renal; hypersensitivity severe.
Alerts/Cautions
Risks
Monitor heart/kidney/mental. Blood tests renal/heart.
Measures
Monitor, low start, adjust; report heart/allergies/mental.
Missed
Actions
Take remembered unless near next; no double, resume.
Strategies
Reminders, schedule; alarms/apps/diary.
Interactions
Medications
Anticholinergics, dopaminergic, antidepressants; reduce efficacy/up effects.
Effects
Affect metabolism/efficacy; e.g., anticholinergics up dry mouth/constipation/confusion. Monitor/adjust.
Avoiding
Inform provider all meds; no change without approval. Review regularly.
Overdose
Signs
Severe dizzy/faint/hallucinate/agitate/irregular beat; emergency.
Actions
Emergency; supportive. Charcoal recent, fluids pressure/heart.
Kinetics
Uptake
Well GI, peaks 2-4 hours; bioavailability ~90%.
Spread
Wide, 5-10 L/kg; crosses brain barrier for CNS.
Breakdown
Minimal liver, unchanged urine; adjust kidney impaired.
Removal
Half-life 10-14 hours normal renal; kidneys mainly.
Forms
Available
Tablet 100 mg, capsule 100 mg, solution 50 mg/5 ml; flexible tailoring.
Benefits
Multiple strengths/forms for preferences/needs; precise adjustments.
Pregnancy/Breastfeeding
Pregnancy
Use if benefit > fetal risk; limited human, animal adverse. Discuss.
Breastfeeding
Excreted milk; decide discontinue breastfeeding/drug per importance. Consult.
Storage
Recommendations
Room 20-25°C, original closed, out child/pet.
Instructions
Cool/dry, away sun/moisture; per manufacturer.
Expiry
No use past; proper storage effective/safe. Dispose regulations.
Trials/Efficacy
Overview
Extensive trials influenza/Parkinson's/movement; randomized placebo thousands worldwide.
Findings
Cuts influenza symptoms, improves Parkinson's motor, treats movements; better outcomes/quality vs placebo.
Comparative
Effective relief, good safety; dual/flexible preferred.
Wrap-Up
Key Points
Effective antiviral/dopaminergic for influenza/Parkinson's/movements; dual benefits, tolerated, safety documented.
Recommendations
Follow dosing/admin; monitor/follow-ups manage effects. Healthy lifestyle diet/exercise support.
Thoughts
Improves quality for influenza/Parkinson's/movements by managing symptoms/well-being. Proven, trusted.